Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07264478

Diagnosis and Treatment Status and Medical Burden of Respiratory Syncytial Virus Infection in Children in China

To understand the diagnosis and treatment status and medical burden of respiratory syncytial virus (RSV) infection in children in China, and to provide scientific basis for formulating prevention and treatment strategies for children. According to the seven administrative regions of China, namely Northeast, North, Northwest, Southwest, Central, South and East China, 1-3 children's medical institutions were selected from each region, and the cases of bronchiolitis or pneumonia admitted to hospitals and diagnosed as RSV positive by etiology during January 1, 2017 to December 31, 2021 were selected. Demographic data and clinical information were collected, and subgroup analysis was designed to explore the relationship between them and medical expenses and clinical treatment burden.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

RSV Infection Disease Burden Infections Mononegavirales Infections Paramyxoviridae Infections Pneumovirus Infections RNA Virus Infections Respiratory Syncytial Virus Infections Virus Diseases

Age range

0 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Beijing Children's Hospital

Beijing, Beijing Municipality, 100045, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Hospitalized patients under 18 years of age with an etiological diagnosis of RSV-positive bronchiolitis or pneumonia

Exclusion criteria

Inpatients under 18 years of age with an etiological diagnosis of RSV-positive bronchiolitis or pneumonia are excluded from any of the following criteria:

  • Pneumonia occurring 48 hours after hospitalization;
  • Combined with bronchial foreign body;
  • Participants in clinical trials of drugs or medical devices;
  • Not complete personal and family history and other relevant information.

Treatment and study plan

uninvolved

Other

uninvolved

Primary outcomes

  1. hospitalization costs

    Time frame: duration of hospital stay

    hospitalization costs,pharmcost,testcost,testcost

Secondary outcomes

  1. hospital day

    Time frame: duration of hospital stay

    duration of hospital stay

Sponsors and collaborators

Lead sponsor

Beijing Children's Hospital

Other

Registry information

Official study title

Beijing Children's Hospital, Capital Medical University, China National Clinical Research Center of Respiratory Diseases, National Center for Children's Health, Beijing, China

Important dates

Study start
2022
Primary completion
2025
Study completion
2025
First posted
Dec 4, 2025
Registry last updated
Dec 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.